These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 2294631)
1. Prognosis of nonpalpable infiltrating carcinoma of the breast. Ciatto S; Cecchini S; Iossa A; Grazzini G; Bravetti P; Rosselli del Turco M; Cataliotti L; Cardona G; Bianchi S Surg Gynecol Obstet; 1990 Jan; 170(1):61-4. PubMed ID: 2294631 [TBL] [Abstract][Full Text] [Related]
2. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Di Saverio S; Gutierrez J; Avisar E Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874 [TBL] [Abstract][Full Text] [Related]
3. Results from a multidisciplinary breast center. Analysis of disease discovered. Silverstein MJ; Gamagami P; Masetti R; Legmann MD; Craig PH; Gierson ED Surg Oncol Clin N Am; 1997 Apr; 6(2):301-14. PubMed ID: 9115497 [TBL] [Abstract][Full Text] [Related]
4. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management. Tafra L; Essner R; Brenner RJ; Giuliano AE Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571 [TBL] [Abstract][Full Text] [Related]
5. Factors influencing survival in infiltrating lobular carcinoma of the breast. Sariego J; Byrd M; Kerstein M; Matsumoto T Am Surg; 1993 Jul; 59(7):405-9. PubMed ID: 8391768 [TBL] [Abstract][Full Text] [Related]
6. A ten year study of partial mastectomy for carcinoma of the breast. Stehlin JS; de Ipolyi PD; Greeff PJ; Gutierrez AE; Hardy RJ; Dahiya SL Surg Gynecol Obstet; 1987 Sep; 165(3):191-8. PubMed ID: 3629435 [TBL] [Abstract][Full Text] [Related]
7. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability. Silverstein MJ; Gierson ED; Waisman JR; Colburn WJ; Gamagami P J Am Coll Surg; 1995 Jun; 180(6):700-4. PubMed ID: 7773483 [TBL] [Abstract][Full Text] [Related]
8. Mammographic and histopathologic correlation of nonpalpable lesions of the breast and the reliability of frozen section diagnosis. Tinnemans JG; Wobbes T; Holland R; Hendriks JH; van der Sluis RF; Lubbers EJ; de Boer HH Surg Gynecol Obstet; 1987 Dec; 165(6):523-9. PubMed ID: 2825366 [TBL] [Abstract][Full Text] [Related]
9. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series. Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634 [TBL] [Abstract][Full Text] [Related]
10. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Rosenberg J; Chia YL; Plevritis S Breast Cancer Res Treat; 2005 Jan; 89(1):47-54. PubMed ID: 15666196 [TBL] [Abstract][Full Text] [Related]
11. Conservative surgery for infiltrating lobular breast carcinoma. Salvadori B; Biganzoli E; Veronesi P; Saccozzi R; Rilke F Br J Surg; 1997 Jan; 84(1):106-9. PubMed ID: 9043471 [TBL] [Abstract][Full Text] [Related]
12. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination. Yu H; Levesque MA; Clark GM; Diamandis EP Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775 [TBL] [Abstract][Full Text] [Related]
13. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma? Jayasinghe UW; Bilous AM; Boyages J Breast J; 2007; 13(5):479-85. PubMed ID: 17760669 [TBL] [Abstract][Full Text] [Related]
14. Biologic considerations regarding the one and two step procedures in the management of patients with invasive carcinoma of the breast. Fisher ER; Sass R; Fisher B Surg Gynecol Obstet; 1985 Sep; 161(3):245-9. PubMed ID: 4035540 [TBL] [Abstract][Full Text] [Related]
15. Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Ménard S; Tomasic G; Casalini P; Balsari A; Pilotti S; Cascinelli N; Salvadori B; Colnaghi MI; Rilke F Clin Cancer Res; 1997 May; 3(5):817-9. PubMed ID: 9815754 [TBL] [Abstract][Full Text] [Related]
16. Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Planchard D; Soria JC; Michiels S; Grunenwald D; Validire P; Caliandro R; Girard P; Le Chevalier T Cancer; 2004 Jan; 100(1):28-35. PubMed ID: 14692021 [TBL] [Abstract][Full Text] [Related]
17. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of synchronous bilateral breast carcinomas. Report of 30 patients. Ben Hassouna J; Damak T; Chargui R; Slimene M; Chkir A; Ayadi MA; Mtallah M; Hechiche M; Gamoudi A; Khomsi F; Ben Dhiab T; Rahal K Tunis Med; 2008 Feb; 86(2):155-9. PubMed ID: 18444533 [TBL] [Abstract][Full Text] [Related]
19. Breast carcinoma survival in Europe and the United States. Sant M; Allemani C; Berrino F; Coleman MP; Aareleid T; Chaplain G; Coebergh JW; Colonna M; Crosignani P; Danzon A; Federico M; Gafà L; Grosclaude P; Hédelin G; Macè-Lesech J; Garcia CM; Møller H; Paci E; Raverdy N; Tretarre B; Williams EM; Cancer; 2004 Feb; 100(4):715-22. PubMed ID: 14770426 [TBL] [Abstract][Full Text] [Related]
20. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]